Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

Gynecologic Oncology

Volumn 122, Issue 2, 2011, Pages 356-360

  Aktas, Bahriye ^a   Müller, Volkmar ^b   Tewes, Mitra ^a   Zeitz, Julia ^b   Kasimir Bauer, Sabine ^a   Loehberg, Christian R ^d   Rack, Brigitte ^e   Schneeweiss, Andreas ^f   Fehm, Tanja ^c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Circulating tumor cells; Hormone receptor status; Metastatic breast cancer; Primary breast cancer

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; RNA;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER GROWTH; CANCER PATIENT; CIRCULATING TUMOR CELL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; OPEN STUDY; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 79960453378     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.04.039     Document Type: Article

References (39)

1. T.C. Powles, C. Gordon, and R.C. Coombes Clinical trial of multiple endocrine therapy for metastatic and locally advanced breast cancer with tamoxifen-.aminoglutethimide-danazol compared to tamoxifen used alone Cancer Res 42 1982 3458 3460 Suppl.
2. I.C. Henderson Endocrine therapy of metastatic breast cancer J.R. Harris, S. Hellman, I.C. Henderson, D.W. Kinne, Breast Dis 1991 Lippincott New York 559 603
3. H.B. Muss Endocrine therapy for advanced breast cancer: a review Breast Cancer Res Treat 21 1992 15 26
4. J.M. Raemaekers, L.V. Beex, A.J. Koenders, G.F. Pieters, A.G. Smals, and T.J. Benraa Concordance and discordance of estrogen and progesterone receptor content in sequential biopsies of patients with advanced breast cancer: relation to survival Eur J Cancer Clin Oncol 8 1984 1011 1018 (Pubitemid 14094415)
5. E.E. Lower, E.L. Glass, D.A. Bradley, R. Blau, and S. Heffelfinger Impact of metastatic estrogen receptor and progesterone receptor status on survival Breast Cancer Res Treat 1 2005 65 70 (Pubitemid 40487003)
6. C. Gomez-Fernandez, Y. Daneshbod, M. Nassiri, C. Milikowski, C. Alvarez, and M. Nadji Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer Am J Clin Pathol 130 2008 879 882
7. C. Simmons, N. Miller, W. Geddie, D. Gianfelice, M. Oldfield, and G. Dranitsaris Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases? Ann Oncol 20 2009 1499 1504
8. C. Liedtke, K. Broglio, S. Moulder, L. Hsu, S.W. Kau, and W.F. Symmans Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer Ann Oncol 20 2009 1953 1958
9. S.J. Aitken, J.S. Thomas, S.P. Langdon, D.J. Harrison, and D. Faratian Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases Ann Oncol 6 2009 1254 1261
10. M. Cristofanilli, G.T. Budd, M.J. Ellis, A. Stopeck, J. Matera, and M.C. Miller Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 351 2004 781 791 (Pubitemid 39095313)
11. G.T. Budd, M. Cristofanilli, M.J. Ellis, A. Stopeck, E. Borden, and M.C. Miller Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer Clin Cancer Res 12 2006 6403 6409 (Pubitemid 44799711)
12. M. Cristofanilli, D.F. Hayes, G.T. Budd, M.J. Ellis, A. Stopeck, and J.M. Reuben Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer J Clin Oncol 23 2005 1420 1430
13. M. Tewes, B. Aktas, A. Welt, S. Mueller, S. Hauch, and R. Kimmig Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies Breast Cancer Res Treat 115 2009 581 590
14. S. Riethdorf, and K. Pantel Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization Pathobiology 75 2008 140 148 (Pubitemid 351820732)
15. S. Kasimir-Bauer Circulating tumor cells as marker for risk assessment and treatment monitoring Mol Diagn Ther 13 2009 209 215
16. B. Rack, V. Müller, S. Kasimir-Bauer, C. Schindlbeck, and W. Janni Minimal residual cancer and its clinical relevance Curr Breast Cancer Rep 1 2009 198 206
17. T. Fehm, V. Müller, B. Aktas, W. Janni, A. Schneeweiss, and E. Stickeler HER2 status of circulating tumor cells in metastatic breast cancer patients: a prospective multi-center trial Breast Cancer Res Treat 124 2010 403 412
18. U. Demel, G.P. Tilz, Z. Foeldes-Papp, B. Gutierrez, W.H. Albert, and O. Böcher Detection of tumour cells in the peripheral blood of patients with breast cancer. Development of a new sensitive and specific immunomolecular assay J Exp Clin Cancer Res 23 2004 465 468 (Pubitemid 39490631)
19. V. Zieglschmid, C. Hollmann, B. Gutierrez, W. Albert, D. Strothoff, and E. Gross Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells Anticancer Res 25 2005 1803 1810 (Pubitemid 40896806)
20. S. Lankiewicz, Gutierrez, B. Rivero, and O. Böcher Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment Mol Biotechnol 34 2006 15 28
21. S. Hauch, S. Zimmermann, S. Lankiewicz, V. Zieglschmid, O. Böcher, and W.H. Albert The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients Anticancer Res 27 2007 1337 1341 (Pubitemid 46807280)
22. T. Fehm, O. Hoffmann, B. Aktas, E.F. Solomayer, D. Wallwiener, and R. Kimmig Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells Breast Cancer Res 11 2009 R59
23. B. Aktas, M. Tewes, T. Fehm, S. Hauch, R. Kimmig, and S. Kasimir-Bauer Stem cell and epithelial-mesenchymal transition markers are frequently expressed in metastatic breast cancer patients with circulating tumor cells Breast Cancer Res 11 2009 R46
24. A.F. Chambers, G.N. Naumov, S.A. Vantyghem, and A.B. Tuck Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency Breast Cancer Res 2 2000 400 407 (Pubitemid 32223636)
25. M. Maynadier, P. Nirde, J.M. Ramirez, A.M. Cathiard, N. Platet, and M. Chambon Role of estrogens and their receptors in adhesion and invasiveness of breast cancer cells Adv Exp Med Biol 617 2008 485 491
26. T.H. Huang, F. Wu, G.B. Loeb, R. Hsu, A. Heidersbach, and A. Brincat Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion J Biol Chem 284 2009 18515 18524
27. M. Tanner, P. Jarvinen, and J. Isola Amplification of HER-2/neu and topoisomerase IIalpha in primary and metastatic breast cancer Cancer Res 61 2001 5345 5348 (Pubitemid 32694907)
28. D. Gancberg, A. Di Leo, F. Cardoso, G. Rouas, M. Pedrocchi, and M. Paesmans Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites Ann Oncol 13 2002 1036 1043
29. S.M. Edgerton, D. Moore II, D. Merkel, and A.D. Thor ErbB-2 (HER-2) and breast cancer progression Appl Immunohistochem Mol Morphol 11 2003 214 221 (Pubitemid 37082057)
30. J. Carlsson, H. Nordgren, J. Sjostrom, K. Wester, K. Villman, and N.O. Bengtsson HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review Br J Cancer 90 2004 2344 2348 (Pubitemid 38961898)
31. P. Regitnig, W. Schippinger, M. Lindbauer, H. Samonigg, and S.F. Lax Change of HER-2/neu status in a subset of distant metastases from breast carcinomas J Pathol 203 2004 918 926 (Pubitemid 39089280)
32. J. Zidan, I. Dashkovsky, C. Stayerman, W. Basher, C. Cozacov, and A. Hadary Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease Br J Cancer 93 2005 552 556 (Pubitemid 43079998)
33. A.C. Wolff, M.E. Hammond, J.N. Schwartz, K.L. Hagerty, D.C. Allred, and R.J. Cote American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 2006 118 134
34. A. Vincent-Salomon, J.Y. Pierga, J. Couturier, C.D. d'Enghien, C. Nos, and B. Sigal-Zafrani HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management? Br J Cancer 96 2007 654 659
35. Y. Gong, W.F. Symmans, S. Krishnamurthy, S. Patel, and N. Sneige Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma Cancer 102 2004 34 40 (Pubitemid 38209571)
36. M. Arnedos, A. Nerurkar, P. Osin, R. A'Hern, I.E. Smith, and M. Dowsett Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC) Ann Oncol 20 2009 1948 1952
37. N. Ditsch, B. Mayer, M. Rolle, M. Untch, F.W. Schildberg, and I. Funke Estrogen receptor expression profile of disseminated epithelial tumor cells in bone marrow of breast cancer patients Recent Results Cancer Res 162 2003 141 147
38. T. Fehm, N. Krawczyk, E.F. Solomayer, G. Becker-Pergola, S. Dürr-Störzer, and H. Neubauer ERα-status of disseminated tumor cells in bone marrow of primary breast cancer patients Breast Cancer Res 10 2008 R76
39. T. Fehm, O. Hoffmann, B. Aktas, E.F. Solomayer, D. Wallwiener, and R. Kimmig Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells Breast Cancer Res 11 2009 R59